糖皮质激素在支气管哮喘治疗中的进展

Research advances on treatment of giucocorticoid in bronchial asthma

支气管哮喘（简称哮喘）是由多种免疫细胞（如肥大细胞、嗜酸粒细胞、T细胞、中性粒细胞、气道上皮细胞等）和细胞组分参与的变态反应性疾病。目前哮喘的药物治疗中主要包括糖皮质激素，很多研究从糖皮质激素治疗哮喘的机制着手，探讨其作用于哮喘的多个环节。

Bronchial asthma（asthma） is an allergic disorder of lung participated by many sorts of immunocytes and cellular components. Current pharmaceutical treatments for asthma generally include the glucocorticoid,and lots of researches go to further the mechanism of glucocorticoid action, all those results will hopefully approach to the effect on component elements of asthma.